List of Tables
    Table 1. Global Secukinumab Sales Growth Rate Comparison by Type (2022-2028) & (Kg) & (US$ Million)
    Table 2. Global Secukinumab Sales Growth Rate Comparison by Application (2022-2028) & (Kg) & (US$ Million)
    Table 3. Global Secukinumab Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Secukinumab Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Secukinumab Sales (Kg) of Key Manufacturers (2017-2022)
    Table 6. Global Secukinumab Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Secukinumab Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Secukinumab Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Secukinumab Average Price (US$/Kg) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Secukinumab Manufacturing Sites and Area Served
    Table 11. Manufacturers Secukinumab Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Secukinumab by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Secukinumab as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Secukinumab Sales by Region (2017-2022) & (Kg)
    Table 16. Global Secukinumab Sales Market Share by Region (2017-2022)
    Table 17. Global Secukinumab Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Secukinumab Revenue Market Share by Region (2017-2022)
    Table 19. North America Secukinumab Sales by Country (2017-2022) & (Kg)
    Table 20. North America Secukinumab Sales Market Share by Country (2017-2022)
    Table 21. North America Secukinumab Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Secukinumab Revenue Market Share by Country (2017-2022)
    Table 23. Europe Secukinumab Sales by Country (2017-2022) & (Kg)
    Table 24. Europe Secukinumab Sales Market Share by Country (2017-2022)
    Table 25. Europe Secukinumab Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Secukinumab Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Secukinumab Sales by Region (2017-2022) & (Kg)
    Table 28. Asia Pacific Secukinumab Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Secukinumab Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Secukinumab Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Secukinumab Sales by Country (2017-2022) & (Kg)
    Table 32. Latin America Secukinumab Sales Market Share by Country (2017-2022)
    Table 33. Latin America Secukinumab Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Secukinumab Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Secukinumab Sales by Country (2017-2022) & (Kg)
    Table 36. Middle East and Africa Secukinumab Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Secukinumab Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Secukinumab Revenue Market Share by Country (2017-2022)
    Table 39. Global Secukinumab Sales by Type (2017-2022) & (Kg)
    Table 40. Global Secukinumab Sales Market Share by Type (2017-2022)
    Table 41. Global Secukinumab Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Secukinumab Revenue Share by Type (2017-2022)
    Table 43. Global Secukinumab Price by Type (2017-2022) & (US$/Kg)
    Table 44. Global Secukinumab Sales (Kg) by Application (2017-2022)
    Table 45. Global Secukinumab Sales Market Share by Application (2017-2022)
    Table 46. Global Secukinumab Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Secukinumab Revenue Share by Application (2017-2022)
    Table 48. Global Secukinumab Price by Application (2017-2022) & (US$/Kg)
    Table 49. Carbosynth Corporation Information
    Table 50. Carbosynth Description and Business Overview
    Table 51. Carbosynth Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 52. Carbosynth Secukinumab Product
    Table 53. Carbosynth Recent Developments/Updates
    Table 54. TargetMol Chemicals Corporation Information
    Table 55. TargetMol Chemicals Description and Business Overview
    Table 56. TargetMol Chemicals Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 57. TargetMol Chemicals Secukinumab Product
    Table 58. TargetMol Chemicals Recent Developments/Updates
    Table 59. Changzhou Chenhong Biotechnology Corporation Information
    Table 60. Changzhou Chenhong Biotechnology Description and Business Overview
    Table 61. Changzhou Chenhong Biotechnology Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 62. Changzhou Chenhong Biotechnology Secukinumab Product
    Table 63. Changzhou Chenhong Biotechnology Recent Developments/Updates
    Table 64. DC Chemicals Corporation Information
    Table 65. DC Chemicals Description and Business Overview
    Table 66. DC Chemicals Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 67. DC Chemicals Secukinumab Product
    Table 68. DC Chemicals Recent Developments/Updates
    Table 69. Huatesheng Biotechnology Corporation Information
    Table 70. Huatesheng Biotechnology Description and Business Overview
    Table 71. Huatesheng Biotechnology Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 72. Huatesheng Biotechnology Secukinumab Product
    Table 73. Huatesheng Biotechnology Recent Developments/Updates
    Table 74. Hubei Guangao Biotechnology Corporation Information
    Table 75. Hubei Guangao Biotechnology Description and Business Overview
    Table 76. Hubei Guangao Biotechnology Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 77. Hubei Guangao Biotechnology Secukinumab Product
    Table 78. Hubei Guangao Biotechnology Recent Developments/Updates
    Table 79. Hubei Kele Fine Chemical Corporation Information
    Table 80. Hubei Kele Fine Chemical Description and Business Overview
    Table 81. Hubei Kele Fine Chemical Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 82. Hubei Kele Fine Chemical Secukinumab Product
    Table 83. Hubei Kele Fine Chemical Recent Developments/Updates
    Table 84. Hubei Widely Chemical Technology Corporation Information
    Table 85. Hubei Widely Chemical Technology Description and Business Overview
    Table 86. Hubei Widely Chemical Technology Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 87. Hubei Widely Chemical Technology Secukinumab Product
    Table 88. Hubei Widely Chemical Technology Recent Developments/Updates
    Table 89. Hubei Xingcheng Biotechnology Corporation Information
    Table 90. Hubei Xingcheng Biotechnology Description and Business Overview
    Table 91. Hubei Xingcheng Biotechnology Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 92. Hubei Xingcheng Biotechnology Secukinumab Product
    Table 93. Hubei Xingcheng Biotechnology Recent Developments/Updates
    Table 94. Hubei Zhongshan Medical Technology Corporation Information
    Table 95. Hubei Zhongshan Medical Technology Description and Business Overview
    Table 96. Hubei Zhongshan Medical Technology Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 97. Hubei Zhongshan Medical Technology Secukinumab Product
    Table 98. Hubei Zhongshan Medical Technology Recent Developments/Updates
    Table 99. Jiangxi Ruiweier Biotechnology Corporation Information
    Table 100. Jiangxi Ruiweier Biotechnology Description and Business Overview
    Table 101. Jiangxi Ruiweier Biotechnology Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 102. Jiangxi Ruiweier Biotechnology Secukinumab Product
    Table 103. Jiangxi Ruiweier Biotechnology Recent Developments/Updates
    Table 104. Nantong Hi-Future Biotechnology Corporation Information
    Table 105. Nantong Hi-Future Biotechnology Description and Business Overview
    Table 106. Nantong Hi-Future Biotechnology Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 107. Nantong Hi-Future Biotechnology Secukinumab Product
    Table 108. Nantong Hi-Future Biotechnology Recent Developments/Updates
    Table 109. Shanghai Biochempartner Corporation Information
    Table 110. Shanghai Biochempartner Description and Business Overview
    Table 111. Shanghai Biochempartner Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 112. Shanghai Biochempartner Secukinumab Product
    Table 113. Shanghai Biochempartner Recent Developments/Updates
    Table 114. Shanghai Minkai Biotechnology Corporation Information
    Table 115. Shanghai Minkai Biotechnology Description and Business Overview
    Table 116. Shanghai Minkai Biotechnology Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 117. Shanghai Minkai Biotechnology Secukinumab Product
    Table 118. Shanghai Minkai Biotechnology Recent Developments/Updates
    Table 119. Shanghai Yifei Biotechnology Corporation Information
    Table 120. Shanghai Yifei Biotechnology Description and Business Overview
    Table 121. Shanghai Yifei Biotechnology Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 122. Shanghai Yifei Biotechnology Secukinumab Product
    Table 123. Shanghai Yifei Biotechnology Recent Developments/Updates
    Table 124. Shanghai Yu'ang Chemical Corporation Information
    Table 125. Shanghai Yu'ang Chemical Description and Business Overview
    Table 126. Shanghai Yu'ang Chemical Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 127. Shanghai Yu'ang Chemical Secukinumab Product
    Table 128. Shanghai Yu'ang Chemical Recent Developments/Updates
    Table 129. Sichuan Weiqi Biotechnology Corporation Information
    Table 130. Sichuan Weiqi Biotechnology Description and Business Overview
    Table 131. Sichuan Weiqi Biotechnology Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 132. Sichuan Weiqi Biotechnology Secukinumab Product
    Table 133. Sichuan Weiqi Biotechnology Recent Developments/Updates
    Table 134. Taizhou KEDE Chemical Corporation Information
    Table 135. Taizhou KEDE Chemical Description and Business Overview
    Table 136. Taizhou KEDE Chemical Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 137. Taizhou KEDE Chemical Secukinumab Product
    Table 138. Taizhou KEDE Chemical Recent Developments/Updates
    Table 139. WeiShi Reagent Corporation Information
    Table 140. WeiShi Reagent Description and Business Overview
    Table 141. WeiShi Reagent Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 142. WeiShi Reagent Secukinumab Product
    Table 143. WeiShi Reagent Recent Developments/Updates
    Table 144. Wuhan Dingxintong Pharmaceutical Corporation Information
    Table 145. Wuhan Dingxintong Pharmaceutical Description and Business Overview
    Table 146. Wuhan Dingxintong Pharmaceutical Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 147. Wuhan Dingxintong Pharmaceutical Secukinumab Product
    Table 148. Wuhan Dingxintong Pharmaceutical Recent Developments/Updates
    Table 149. Wuhan Fortuna Chemical Corporation Information
    Table 150. Wuhan Fortuna Chemical Description and Business Overview
    Table 151. Wuhan Fortuna Chemical Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 152. Wuhan Fortuna Chemical Secukinumab Product
    Table 153. Wuhan Fortuna Chemical Recent Developments/Updates
    Table 154. Wuhan Topule Biopharmaceutical Corporation Information
    Table 155. Wuhan Topule Biopharmaceutical Description and Business Overview
    Table 156. Wuhan Topule Biopharmaceutical Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 157. Wuhan Topule Biopharmaceutical Secukinumab Product
    Table 158. Wuhan Topule Biopharmaceutical Recent Developments/Updates
    Table 159. Wuhan Weisman Bioengineering Corporation Information
    Table 160. Wuhan Weisman Bioengineering Description and Business Overview
    Table 161. Wuhan Weisman Bioengineering Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 162. Wuhan Weisman Bioengineering Secukinumab Product
    Table 163. Wuhan Weisman Bioengineering Recent Developments/Updates
    Table 164. Wuhan Yingnuo Pharmaceutical Technology Corporation Information
    Table 165. Wuhan Yingnuo Pharmaceutical Technology Description and Business Overview
    Table 166. Wuhan Yingnuo Pharmaceutical Technology Secukinumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 167. Wuhan Yingnuo Pharmaceutical Technology Secukinumab Product
    Table 168. Wuhan Yingnuo Pharmaceutical Technology Recent Developments/Updates
    Table 169. Production Base and Market Concentration Rate of Raw Material
    Table 170. Key Suppliers of Raw Materials
    Table 171. Secukinumab Distributors List
    Table 172. Secukinumab Customers List
    Table 173. Secukinumab Market Trends
    Table 174. Secukinumab Market Drivers
    Table 175. Secukinumab Market Challenges
    Table 176. Secukinumab Market Restraints
    Table 177. Global Secukinumab Sales Forecast by Type (2023-2028) & (Kg)
    Table 178. Global Secukinumab Sales Market Share Forecast by Type (2023-2028)
    Table 179. Global Secukinumab Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 180. Global Secukinumab Revenue Market Share Forecast by Type (2023-2028)
    Table 181. Global Secukinumab Sales Forecast by Application (2023-2028) & (Kg)
    Table 182. Global Secukinumab Sales Market Share Forecast by Application (2023-2028)
    Table 183. Global Secukinumab Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 184. Global Secukinumab Revenue Market Share Forecast by Application (2023-2028)
    Table 185. Global Secukinumab Sales Forecast by Region (2023-2028) & (Kg)
    Table 186. Global Secukinumab Sales Market Share Forecast by Region (2023-2028)
    Table 187. Global Secukinumab Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 188. Global Secukinumab Revenue Market Share Forecast by Region (2023-2028)
    Table 189. Research Programs/Design for This Report
    Table 190. Key Data Information from Secondary Sources
    Table 191. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Secukinumab
    Figure 2. Global Secukinumab Market Share by Type in 2021 & 2028
    Figure 3. Patent Product Picture
    Figure 4. Generic Product Picture
    Figure 5. Global Secukinumab Market Share by Application in 2021 & 2028
    Figure 6. Chemical
    Figure 7. Pharmaceutical
    Figure 8. Global Secukinumab Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 9. Global Secukinumab Market Size (2017-2028) & (US$ Million)
    Figure 10. Global Secukinumab Sales (2017-2028) & (Kg)
    Figure 11. Secukinumab Sales Share by Manufacturers in 2021
    Figure 12. Global Secukinumab Revenue Share by Manufacturers in 2021
    Figure 13. The Global 5 and 10 Largest Secukinumab Players: Market Share by Revenue in 2021
    Figure 14. Secukinumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 15. Global Secukinumab Sales Market Share by Region (2017-2022)
    Figure 16. Global Secukinumab Sales Market Share by Region in 2021
    Figure 17. Global Secukinumab Revenue Market Share by Region (2017-2022)
    Figure 18. Global Secukinumab Revenue Market Share by Region in 2021
    Figure 19. United States Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 20. Canada Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Germany Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. France Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. U.K. Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Italy Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Russia Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. China Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Japan Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. South Korea Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. India Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Australia Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. China Taiwan Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Indonesia Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Thailand Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Malaysia Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Mexico Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Brazil Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Argentina Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Turkey Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Saudi Arabia Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. UAE Secukinumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Sales Market Share of Secukinumab by Type (2017-2022)
    Figure 42. Manufacturing Cost Structure of Secukinumab
    Figure 43. Manufacturing Process Analysis of Secukinumab
    Figure 44. Secukinumab Industrial Chain Analysis
    Figure 45. Channels of Distribution
    Figure 46. Distributors Profiles
    Figure 47. Bottom-up and Top-down Approaches for This Report
    Figure 48. Data Triangulation
    Figure 49. Key Executives Interviewed